Mass azithromycin administration: considerations in an increasingly resistant world
Abstract
### Summary box
Azithromycin is an oral macrolide discovered in 1980 and approved for medical use in 1988.1 This relatively inexpensive antibiotic is often deemed as a wonder drug due to its safety and effectiveness against parasitic and helminth infections, in addition to a wide range of bacterial infections. In the early 2000s, biannual administration of azithromycin (mass drug administration, MDA) for trachoma control was found to reduce...
Paper Details
Title
Mass azithromycin administration: considerations in an increasingly resistant world
Published Date
Jun 1, 2020
Journal
Volume
5
Issue
6
Pages
e002446 - e002446
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History